| Active substance |
SARMs |
| Also known as |
Enobosarm, GTx-024 |
| Blood pressure |
No significant impact |
| Chemical name |
(2S)-3-(4-cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide |
| Dosage (medical) |
Not medically approved, no standard dosage |
| Dosage (sports) |
10-30 mg per day |
| Effects |
Increases muscle mass and strength, improves bone density |
| Formula |
C19H14F3N3O3 |
| Half-life |
24 hours |
| Hepatotoxicity |
Mild risk |
| Lab Test |
Detection in blood and urine through specific chromatographic techniques |
| Main action |
Anabolic, muscle growth stimulation |
| Side effects |
Possible liver toxicity, changes in lipid profiles, suppression of natural testosterone production |
| Storage conditions |
Store at room temperature away from moisture and light |
| Substance class |
Selective Androgen Receptor Modulator (SARM) |
| Trade name |
Enobosarm |
| Use in sports |
Used for muscle growth and performance enhancement, banned in professional sports |
| Water Retention |
Minimal |
| Active ingredient, mg |
10 |
| Release form |
Capsule |
| Manufacturer |
Elbrus Pharmaceuticals |
| Packing |
Packaging (60 capsules) |
